Active Genomes Expressed Diagnostics
Washington, US · Founded 2021
Founders & leadership
RZ
Rachel ZayasExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$250KraisedFeb 2023 · 2 investors · Other TechnologyRule 506(b)
▶$250KraisedFeb 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Rachel ZayasExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $250K
- Minimum investment
- $100K
- First sale
- Dec 2022
- Incorporated
- Corporation, District Of Columbia, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.